Is pharmaceutical industry oligopoly

Yes, the pharmaceutical industry can be considered an oligopoly due to the dominance of a few large companies that control a significant share of the market. These firms often engage in similar strategies regarding pricing, research and development, and marketing, leading to limited competition. Barriers to entry, such as high costs and regulatory hurdles, further reinforce this oligopolistic structure. As a result, innovation and pricing can be influenced heavily by the actions of these major players.